ChemDiv and Berlex Announce Lead Compound Discovery Collaboration
ChemDiv, Inc. announced that it has entered into a discovery research collaboration with Berlex Inc., a U.S. affiliate of Schering AG, Germany. The partners will work on the discovery of potential new lead compounds against several selected GPCR targets.
Under the terms of the collaboration, ChemDiv will apply its integrated synthetic and medicinal chemistry capabilities and collaborate with Berlex's scientists in the search for new disease therapies. Financial terms were not disclosed.
Organizations
Other news from the department business & finance

Get the life science industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.
Most read news
More news from our other portals
Last viewed contents
Biograil secures seed funding for oral delivery device with potential to transform market for injectables
Ben-Gurion University of the Negev Alzheimer's Researcher demostrates specific immune response to vaccine

'Breathing' enzymes in fast motion - Researchers watch work of an enzyme in unprecedented detail
Diosynth Biotechnology enters long-term commercial supply agreement with Dendreon
